Skip to content
Lower risk Medical device recall · FDA · Published March 15, 2019

Cytocell Aquarius Probe Red Recalled Due to Labeling Error

Cytocell recalls Aquarius CSF1R/RPS14 Probe Red reagent (model LPH540-A) with lot numbers 056996, 061156, 062616, 062808 due to a labeling error in the chromomap.

🇺🇸 FDA recall #Z-1202-2019Medical deviceCytoc:ell ›
Take action

Contact the company

Recalling firmCytocell Ltd.Somerville Court, Unit 8, Banbury Business Park · Adderbury Banbury Oxfordshire, United Kingdom
✎ GovInfoNow plain-language explainer

What happened, in plain English

Cytocell is recalling a specific reagent used in laboratory testing because the labeling contains an error in the chromomap. This error could lead to incorrect test results if the reagent is used without proper understanding of the labeling. Read more at govinfonow.com/recall/68686-cytocell-aquarius-probe-red-recalled-due-to-labeling-error.

Source Summary by GovInfoNow · govinfonow.com/recall/68686-cytocell-aquarius-probe-red-recalled-due-to-labeling-error · Updated August 20, 2026 · FDA enforcement record: FDA #Z-1202-2019

Cite this page

“Cytocell Aquarius Probe Red Recalled Due to Labeling Error.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/68686-cytocell-aquarius-probe-red-recalled-due-to-labeling-error. Based on FDA recall #Z-1202-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1202-2019%22&limit=1).

Why it’s dangerous

The labeling error in the chromomap could cause laboratory users to misinterpret the product's specifications, potentially leading to inaccurate test results. This is a technical error that does not pose a physical safety risk but affects the accuracy of the reagent's use.

Who’s affected

Laboratory users who purchased the Aquarius CSF1R/RPS14 Probe Red reagent (model LPH540-A) with lot numbers 056996, 061156, 062616, or 062808 are affected. Researchers and technicians working with this reagent are most at risk of incorrect test results.

How to tell if you have this one

Check the lot number on the reagent's packaging. The affected model is LPH540-A with lot numbers 056996, 061156, 062616, or 062808. This reagent is used in laboratory settings for specific analyte testing.

  • Brand
    Cytoc:ell
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Lot Number

    Look for the lot numbers 056996, 061156, 062616, or 062808 on the reagent packaging.

Where it went and when

Where it was distributed

Distributed in Illinois and Tennessee.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: yesILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: yesTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “The products were distributed to the following US states: IL, TN.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Illinois, Tennessee.

Recall timeline

FDA terminated this recall 19 months after the firm started it.

1. Firm started the recall: Mar 15, 201912. FDA classified it Class III: Apr 19, 201923. Published in FDA’s Enforcement Report: May 1, 201934. FDA terminated the recall: Oct 13, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1202-2019 (March 15, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1202-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA